NCT01064713 2018-07-17Phase II Study of Tesetaxel in Metastatic MelanomaM.D. Anderson Cancer CenterPhase 2 Completed17 enrolled 5 charts
NCT01092585 2011-11-08Tesetaxel as Second-line Therapy for Patients With Advanced Melanoma and Normal Serum LDHGenta IncorporatedPhase 2 Unknown27 enrolled